CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.

Source:http://linkedlifedata.com/resource/pubmed/id/9679898

Download in:

View as

General Info

PMID
9679898